PT  - JOURNAL ARTICLE
AU  - Pansini, Riccardo
AU  - Fornacca, Davide
TI  - COVID-19 higher induced mortality in Chinese regions with lower air quality
AID  - 10.1101/2020.04.04.20053595
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.04.20053595
4099  - http://medrxiv.org/content/early/2020/04/16/2020.04.04.20053595.short
4100  - http://medrxiv.org/content/early/2020/04/16/2020.04.04.20053595.full
AB  - COVID-19 has spread in all continents in a span of just over three months, escalating into a pandemic that poses several humanitarian as well as scientific challenges. We here investigated the geographical expansion of the infection and correlate it with the annual indexes of air quality observed from the Sentinel-5 satellite orbiting around China, Italy and the U.S.A. Controlling for population size, we find more viral infections in those areas afflicted by Carbon Monoxide (CO) and Nitrogen Dioxide (NO2). Higher mortality was also correlated with poor air quality, namely with high PM2.5, CO and NO2 values. In Italy, the correspondence between poor air quality and SARS-CoV-2 appearance and induced mortality was the starkest. Similar to smoking, people living in polluted areas are more vulnerable to SARS-CoV-2 infections and induced mortality. This further suggests the detrimental impact climate change will have on the trajectory of future epidemics.Significance We found a significant correlation between levels of air quality and COVID-19 spread and mortality in China, Italy and the United States. Despite the infection being still ongoing at a global level, these correlations are relatively robust not being influenced by varying population densities. Living in an area with low air quality seems to be a risk factor for becoming infected and dying from this new form of coronavirus.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are going to be available online once peer-reviewed by a journal. https://github.com/DavideFornacca